ZBH

Zimmer Biomet Holdings, Inc.

Healthcare
84.98 +1.23 +1.47% Market Closed
2026-06-03 • USD

Key Metrics

Market Cap 16.44B
EV —
Shares Out 193.46M
Revenue (ttm) 8.41B
Net Income 761.20M
Beta —
P/E 21.77
Forward P/E —
EPS (ttm) $3.86
P/S 1.97
P/B 1.31
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 3.35%
ROE 6.04%
ROIC 4.93%
Gross Margin —
Oper. Margin 14.02%
Profit Margin 9.05%
Debt/Eq 0.59
LT Debt/Eq 33.19%
Quick Ratio —
Current Ratio 1.73
Book/sh 64.99
Cash/sh 2.18
Div Yield 1.13%
Div TTM $0.96
Payout Ratio 24.87%
SMA20 1.67%
SMA50 -2.83%
SMA200 -9.1%
Volume 1,948,024
Avg Volume 2.30M
Rel Volume —
Perf Week 3.22%
Perf Month 2.37%
Perf Quarter -9.06%
Perf Half Y -9.86%
Perf YTD -5.49%
Perf Year -7.55%
Perf 3Y -34.87%
Perf 5Y -44.95%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.2400
TTM Yield 1.13%
TTM Amount $0.96
Payout Ratio 24.87%
3-Yr Growth (CAGR) 0.00%
5-Yr Growth (CAGR) 0.00%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $0.2400
Q4 2025 ~2025-12-30 $0.2400
Q3 2025 ~2025-09-30 $0.2400
Q2 2025 ~2025-06-30 $0.2400
Q1 2025 ~2025-03-31 $0.2400
Q4 2024 ~2024-12-30 $0.2400
Q3 2024 ~2024-09-30 $0.2400
Q2 2024 ~2024-06-30 $0.2400
Q1 2024 ~2024-03-31 $0.2400
Q4 2023 ~2023-12-30 $0.2400
Q3 2023 ~2023-09-30 $0.2400
Q2 2023 ~2023-06-30 $0.2400

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Zimmer Biomet Holdings, Inc. is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. The company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company has operations in more than 25 countries around the world and sells products in more than 100 countries. The company operates in markets characterized by rapidly evolving technologies, complex regulatory requirements and significant competition.

Name
Zimmer Biomet Holdings, Inc.
Industry
Medical Instruments & Supplies
CEO
Ivan Tornos · Chairman, President and Chief Executive Officer
Employees
—
IPO Date
2017-07-11
Phone
(574) 373-3333
Address
345 East Main Street, Warsaw, IN 46580
Website
www.zimmerbiomet.com

Key Executives

Name Title FY Pay
Kevin Thornal Executive Officer —
Jehanzeb Noor Executive Officer —
Wilfred Van Zuilen Executive Officer —
Suketu Upadhyay Chief Financial Officer —
Ivan Tornos Chairman, President and Chief Executive Officer —

Latest News